Implantable Neurostimulation Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Technology ( spinal cord stimulation (SCS), deep brain stimulation (DBS), sacral nerve stimulation (SNS), gastric electric stimulation (GES), vagus nerve stimulation (VNS), others ); Application ( pain management, epilepsy, Parkinson's, urinary and fecal incontinence, others )
Report Code: TIPRE00011785 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET OVERVIEW
The neurostimulation devices market refers to devices that amplifies electrical stimulation to treat various neurological conditions. These devices deliver small electrical impulses to specific areas of the brain or spinal cord to help alleviate symptoms such as chronic pain, movement disorders, and other conditions. The market for neurostimulation devices has been rapidly growing due to the increasing prevalence of neurological disorders and the growing awareness of the benefits of neurostimulation therapy. The market is segmented into product such as spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and gastric electric stimulator.
MARKET DYNAMICS
Rising cases of migraine and epilepsy and introduction of technologically advanced products are anticipated to fuel the growth of neurostimulation devices market during the forecast period. The neurostimulation devices implantation a non-invasive surgery with short hospital stays & faster recovery are significant growth opportunities to the players operating in the neurostimulation devices market.
MARKET SCOPE
The "Global Neurostimulation Devices Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by product, application and geography. The global neurostimulation devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global neurostimulation devices market is segmented on the basis of product and application. Based on product, the market is segmented as, spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and gastric electric stimulator. Based on application, the neurostimulation devices market is categorized as, pain management, epilepsy, urinary and fecal incontinence, depression, Parkinson’s disease, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global neurostimulation devices market based on product and application. It also provides market size and forecast till 2028 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The neurostimulation devices market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region. North America is expected to contribute to the largest share in the neurostimulation devices market in the coming years, owing to presence of established players in the region. Asia Pacific is expected to witness significant growth during the forecast period, owing to rising healthcare expenditures, along with presence of untapped medical needs. The report analyzes factors affecting neurostimulation devices market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the neurostimulation devices market in these regions.
The report also includes the profiles of key neurostimulation devices manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the neurostimulation devices market include, Abbott, Boston Scientific Corporation, Cogentix Medical, Elkem Silicones, Integer Holdings Corporation, LivaNova, Inc., Medtronic, Neuronetics, Neuros Medical, and Nevro Corp among others.
The List of Companies
1. BioControl Medical
2. Boston Scientific Corporation
3. Cyberonics, Inc.
4. Medtronic Inc.
5. Nevro Corporation
6. Spinal Modulation
7. St. Jude Medical,
8. Synapse Biomedical Inc.
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount